Urology

Urology
Audio Summaries

The literature in urology doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

7 active journals1,240 audio summaries

Recent summaries

The latest articles summarized from urology journals.

Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication

Lancet (London, England)|May 10, 2026

The authors aimed to evaluate the efficacy and safety of endovascular thrombectomy in patients with large-core ischaemic stroke presenting within 24 hours of onset, a group often excluded from such treatments. Their systematic review and meta-analysis of individual patient data from six trials found that endovascular thrombectomy significantly improved functional outcomes and reduced mortality compared to medical management, although the benefits were less clear for patients with very large ischaemic core volumes (≥150 mL). Overall, the findings suggest that endovascular thrombectomy is beneficial for most patients with large-core ischaemic strokes, except in cases of extensive ischaemic changes presenting beyond 6 hours.

Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis

JAMA|May 10, 2026

The authors aimed to evaluate the efficacy and safety of digitalis glycosides in patients with heart failure with mildly reduced ejection fraction (HFmrEF) or reduced ejection fraction (HFrEF). Their meta-analysis of three randomized controlled trials involving 9,013 patients found that digitalis glycosides significantly reduced the risk of cardiovascular death or first worsening heart failure event, primarily by lowering the incidence of worsening heart failure. These findings suggest that digitalis glycosides may be a beneficial adjunct therapy for managing these heart failure conditions.

Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme

Lancet (London, England)|May 10, 2026

This study evaluates the impact of the RTS,S/AS01<sub>E</sub> malaria vaccine on mortality rates in young children in Ghana, Kenya, and Malawi over a 46-month period following its introduction in 2019. The authors aimed to determine whether the vaccine significantly reduced overall mortality in children eligible for three doses compared to non-eligible children, finding a notable reduction in mortality, with approximately one in eight deaths averted in areas with moderate vaccine coverage. The results underscore the importance of accelerating malaria vaccine deployment in regions where malaria remains a leading cause of child mortality.

Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial

Lancet (London, England)|May 10, 2026

This study aimed to evaluate the efficacy and safety of enpatoran, a TLR7/8 inhibitor, in improving disease activity in patients with moderate-to-severe systemic lupus erythematosus (SLE) compared to placebo. Although enpatoran showed improved British Isles Lupus Assessment Group-based Composite Lupus Assessment (BICLA) response rates at various doses, the primary objective of demonstrating a statistically significant dose-response relationship was not achieved. Overall, enpatoran was well tolerated among participants.

Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial

JAMA|May 10, 2026

The study aimed to determine whether digoxin improves outcomes related to death or worsening heart failure in patients with symptomatic rheumatic heart disease compared to a placebo. The results indicated that digoxin significantly reduced the risk of the composite outcome of all-cause death or new-onset/worsening heart failure, with a low incidence of toxicity. Overall, digoxin appears to be a beneficial treatment option for this patient population.

The role of community-based blood pressure screening in improving hypertension care

Lancet (London, England)|May 9, 2026

The authors argue against the viewpoint that mass blood pressure screening detracts from hypertension care, positing instead that community-based screening can enhance hypertension detection, especially in underserved populations. They emphasize that such screening, when conducted with validated methods, can effectively identify individuals with elevated blood pressure and raise awareness about hypertension, ultimately supporting better management and control of the condition. The paper advocates for integrating community screening with primary care to address the global challenge of hypertension.

Effect of Intravesical Administration of Steroid Enemas on an Experimental Autoimmune Interstitial Cystitis-Like Mouse Model

Neurourology and urodynamics|May 8, 2026

The authors investigate the potential of intravesical steroid enemas as a treatment for interstitial cystitis/bladder pain syndrome (IC/BPS) using an experimental autoimmune interstitial cystitis (EAIC) mouse model. They compare the effects of steroid enemas to traditional dimethyl sulfoxide (DMSO) treatment, finding that steroid enemas provide superior anti-inflammatory benefits and improved bladder function without causing tissue damage or adverse effects. This study suggests that steroid enemas could be a practical and patient-friendly therapeutic option for IC/BPS, warranting further research.

A Dual-Task Deep-Learning Model with Fused Ultrasound Images for Simultaneous Typing and Grading of Cystocele

International urogynecology journal|May 8, 2026

The authors aimed to develop and evaluate a dual-task deep-learning model, FD-Net, that utilizes fused 2D and 3D ultrasound images to automate the typing and grading of cystocele. Their results demonstrated that FD-Net outperformed single-modal models in diagnostic accuracy and F1-scores, suggesting its potential for clinical application in cystocele assessment.

Clinical Characteristics and Diagnostic Markers of Genital Varicella-zoster in Women: A 12-year Retrospective Cohort

Journal of lower genital tract disease|May 8, 2026

The authors aimed to characterize the clinical features and diagnostic challenges of genital varicella-zoster virus (VZV) reactivation in women, given its rarity and frequent misdiagnosis. Their retrospective study of 21 female patients revealed that genital zoster is often misidentified as herpes simplex virus (HSV) or other conditions, highlighting key features such as unilateral distribution, pain, and extragenital extension that could improve diagnostic accuracy. The findings underscore the need for better recognition of genital zoster to reduce misclassification and associated psychosocial impacts.

Holistic Pelvic Floor: Pelvic Floor Stress Dysfunction Diseases

International urogynecology journal|May 8, 2026

The authors aim to address the complexities of pelvic floor stress dysfunction diseases (PFSD) by advocating for a holistic approach to understanding and treating these conditions. They highlight the importance of recognizing the underlying biomechanical and etiological factors contributing to PFSD, suggesting a shift from symptom-focused treatments to those based on the mechanisms of the disease. The article discusses current advancements, challenges, and future directions in the management of PFSD.

Start listening to urology research

14-day free trial. Pick your journals and go.